Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
KLBF.JK
Strong BuyUnloved QualityPT Kalbe Farma Tbk. · Healthcare · Indonesia · $2.0B · Avg Vol: $4M/d
94
StockRankGet insider-trade alerts
Q
80
V
79
M
40
P/E (TTM)
9.6x
ROE
14.8%
D/E
0.0x
Dividend %
2.6%
COMPANY DESCRIPTION
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments.
FINANCIAL SUMMARY (IDR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.9T | 30.4T | 32.6T | 35.3T | 6.9% | 37.7T | 38.6T | 41.8T | 8.7% |
| EPS (IDR) | 72.71 | 59.81 | 70.16 | 80.51 | 3.5% | 79.56 | 80.22 | 86.85 | 3.9% |
| Shares | 46.3B | 46.3B | 46.0B | 45.3B | -2.1% | 45.2B | — | — | — |
| Debt | 1.2T | 618.5B | 559.2B | 297.3B | -36.6% | 826.5B | — | — | — |
| Equity | 20.4T | 21.4T | 22.8T | 23.3T | 4.6% | — | — | — | — |
| Op CF | 1.3T | 2.9T | 4.8T | 3.3T | 37.0% | 3.2T | — | — | — |
| Inv CF | -1.4T | -1.1T | -1.2T | -799.9B | — | — | — | — | — |
| Fin CF | -2.4T | -2.4T | -2.1T | -2.9T | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+10.0%
SMA 50SMA 200
Close
$0.044
RSI (14)
28.0
52W High
$0.0747
From 52W High
0.6%
SCORE BREAKDOWN
Quality
80
ROIC
19.0%89.3
ROE
14.8%81.7
GP/Assets
45.9%83.3
Op. Margin
11.9%67.5
FCF/Assets
6.5%76.1
Piotroski
783.9
Int. Cover
50.0x89.2
D/E Ratio
0.03x75.6
Current Ratio
3.15x57.4
Value
79
P/E (TTM)
9.6x90.4
EV/EBITDA
6.4x86.8
P/FCF
17.4x67.4
P/B
1.4x75.5
P/S
0.9x85.9
Div Yield
2.6%61.3
Momentum
40
52W High %
59%32.8
RS 6M
-4%60.2
SMA 50/200
0.81x18.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-1%36.1
FUNDAMENTALS
Market Cap
$2.0B
P/E (Forward)
10.2x
Gross Margin
37.4%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KLBF.JK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KLBF.JK | PT Kalbe Farma Tbk.(you) | $2.0B | 94 | Strong Buy |
| MIKA.JK | PT Mitra Keluarga Karyasehat Tbk | $1.5B | 84 | Strong Buy |
| SILO.JK | PT Siloam International Hospitals Tbk | $1.6B | 78 | Buy |
| SOHO.JK | PT Soho Global Health Tbk | $1.2B | 57 | Hold |
| MARK.JK | PT Mark Dynamics Indonesia Tbk | $233M | 100 | Strong Buy |
| PRDA.JK | PT Prodia Widyahusada Tbk | $142M | 100 | Strong Buy |
| HEAL.JK | PT Medikaloka Hermina Tbk | $589M | 35 | Sell |
| SAME.JK | PT Sarana Meditama Metropolitan Tbk | $308M | 46 | Hold |
| LPKR.JK | PT Lippo Karawaci Tbk | $249M | 40 | Hold |
| KAEF.JK | PT Kimia Farma Tbk | $150M | 35 | Hold |
Peer medians: ROE 7.3% · P/E 20.2x · Gross margin 35.8%